Talha H Imam1. 1. Nephrologist at the Fontana Medical Center in California, USA. talha.h.imam@kp.org
Abstract
BACKGROUND: Propofol is a popular anesthetic and sedative. Use of propofol has increased manifold in this country over the last decade, and it is most commonly used in intensive care settings. Its rapid action with short half-life, decreased cerebral oxygen consumption, and reduction of intracranial pressure are properties that have made it a favorite in the intensive care unit. Many of these patients are critically ill or injured and require prolonged sedation. Propofol has been associated with morbidity and mortality, and in such cases the question often arises regarding the role propofol plays in these complications. OBJECTIVE: To address the issue of propofol-related infusion syndrome and its management. METHOD: A hypothetical clinical vignette was created to give a classic presentation of propofol-related infusion syndrome. CONCLUSION: It is hoped that this short report will bring more awareness of this entity so that it will be considered in the differential diagnosis in sedated critical care patients.
BACKGROUND:Propofol is a popular anesthetic and sedative. Use of propofol has increased manifold in this country over the last decade, and it is most commonly used in intensive care settings. Its rapid action with short half-life, decreased cerebral oxygen consumption, and reduction of intracranial pressure are properties that have made it a favorite in the intensive care unit. Many of these patients are critically ill or injured and require prolonged sedation. Propofol has been associated with morbidity and mortality, and in such cases the question often arises regarding the role propofol plays in these complications. OBJECTIVE: To address the issue of propofol-related infusion syndrome and its management. METHOD: A hypothetical clinical vignette was created to give a classic presentation of propofol-related infusion syndrome. CONCLUSION: It is hoped that this short report will bring more awareness of this entity so that it will be considered in the differential diagnosis in sedated critical care patients.
Authors: Judith Jacobi; Gilles L Fraser; Douglas B Coursin; Richard R Riker; Dorrie Fontaine; Eric T Wittbrodt; Donald B Chalfin; Michael F Masica; H Scott Bjerke; William M Coplin; David W Crippen; Barry D Fuchs; Ruth M Kelleher; Paul E Marik; Stanley A Nasraway; Michael J Murray; William T Peruzzi; Philip D Lumb Journal: Crit Care Med Date: 2002-01 Impact factor: 7.598
Authors: Kevin Vernooy; Tammo Delhaas; Olaf L Cremer; José M Di Diego; Antonio Oliva; Carl Timmermans; Paul G Volders; Frits W Prinzen; Harry J G M Crijns; Charles Antzelevitch; Cornelis J Kalkman; Luz-Maria Rodriguez; Ramon Brugada Journal: Heart Rhythm Date: 2006-02 Impact factor: 6.343
Authors: Jeffrey J Fong; Lynne Sylvia; Robin Ruthazer; Greg Schumaker; Marisol Kcomt; John W Devlin Journal: Crit Care Med Date: 2008-08 Impact factor: 7.598
Authors: Russel J Roberts; Jeffrey F Barletta; Jeffrey J Fong; Greg Schumaker; Philip J Kuper; Stella Papadopoulos; Dinesh Yogaratnam; Elise Kendall; Renee Xamplas; Anthony T Gerlach; Paul M Szumita; Kevin E Anger; Paul A Arpino; Stacey A Voils; Philip Grgurich; Robin Ruthazer; John W Devlin Journal: Crit Care Date: 2009-10-29 Impact factor: 9.097